evAluation of Glycemic RangE During acutE Coronary syndroME in Nondiabetic paTients (AGREEMENT)

University of Pavia

Status and phase: Completed; Phase 4

Conditions: Acute Coronary Syndrome

Treatments: Device: Continuous Glucose Monitoring System (i Pro 2 - Medtronic)

Study type: Interventional

Funder types: Other

Identifiers

NCT02932592

20160000072

Details and patient eligibility

About

To evaluate the glycemic variations during acute coronary syndrome in non-diabetic patients (euglycemic, or with impaired fasting glucose, or with impaired glucose tolerance)

Full description

All nondiabetic patients with dysglycemia (fasting plasma glucose between 100 and 125 mg/dl) will be monitored with a device (Continuous Glucose Monitoring System) and all these patients will be undergone an oral glucose tolerance test after the discharge from this Unit.

Enrollment: 196 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• nondiabetic patients
• acute coronary syndrome

Exclusion criteria

• diabetic patients

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

196 participants in 1 patient group

Dysglycemic group

Experimental group

Description:

Patients with dysglycemia (not diabetic patients) will be undergone a monitoring of blood glucose with a device till the discharge of the patient. Then, an oral glucose tolerance test (OGTT) will be done to categorize the patient as having impaired fasting glucose (IFG) or impaired glucose tolerance (IGT), or diabetes mellitus.

Treatment:

Device: Continuous Glucose Monitoring System (i Pro 2 - Medtronic)